Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Ophthalmology. 2017 Dec 2;125(4):569–577. doi: 10.1016/j.ophtha.2017.10.033

Table 1.

Characteristics of Persons in the Training and Testing Datasets

Total Training Testing p-value*
No. or Mean % or SD No. or Mean % or SD No. or Mean % or SD
No. of participants 571 100% 286 50% 285 50%
Trial 0.71
CIGTS 266 100% 131 49% 135 51%
AGIS 305 100% 155 51% 150 49%
Sex 0.87
Male 272 48% 135 47% 137 48%
Female 299 52% 151 53% 148 52%
Race 0.26
Black 288 50% 154 54% 134 47%
White 263 46% 123 43% 140 49%
Other 20 4% 9 3% 11 4%
Mean (SD) no. of visits per patient 11.2 5.1 11.0 5.0 11.3 5.3 0.49
Mean (SD) of age [years] 64.2 10.9 64.2 10.9 64.3 11.0 0.91
Mean (SD) of baseline MD [dB] −7.49 5.39 −7.39 5.53 −7.59 5.26 0.66
Mean (SD) of baseline PSD [dB] 6.42 3.69 6.45 3.68 6.39 3.70 0.85
Mean (SD) of baseline IOP [mmHg] 17.62 3.60 17.63 3.35 17.62 3.83 0.97
Progressor Status § 0.71
Fast 121 21% 58 20% 63 22%
Slow 267 47% 132 46% 135 47%
Non 183 32% 96 34% 87 31%

IOP = intraocular pressure; MD = mean deviation; PSD = pattern standard deviation; SD = standard deviation; AGIS = Advanced Glaucoma Intervention Study; CIGTS = Collaborative Initial Glaucoma Treatment Study; mmHg = millimeter of mercury; dB = decibels.

*

Fisher Exact Test and Student’s t-test were used for categorical and continuous variables, respectively.

All participants contributed only one eye.

Each visit includes tonometry and perimetric testing.

§

Designation of progression status for each patient was made based on all MD readings for that patient using the criteria described in the Methods section. Further, the fast-, slow-, and non-progressor patient sets are mutually exclusive subsets of the whole data set.